info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Microbiome Sequencing Services Market Research Report: Information By Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Others), By Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/6063-HCR | 160 Pages | Author: Kinjoll Dey| November 2024

Market Segmentation


Microbiome Sequencing Services Technology Outlook (USD Billion, 2018-2032)




  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others




Microbiome Sequencing Services Application Outlook (USD Billion, 2018-2032)




  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology






  • Others




Microbiome Sequencing Services Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)






  • North America Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • North America Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology




    • Others









    • US Outlook (USD Billion, 2018-2032)







  • US Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • US Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • CANADA Outlook (USD Billion, 2018-2032)







  • CANADA Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • CANADA Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology







    • Others





  • Europe Outlook (USD Billion, 2018-2032)






  • Europe Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Europe Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology




  • Others







    • Germany Outlook (USD Billion, 2018-2032)







  • Germany Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Germany Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • France Outlook (USD Billion, 2018-2032)







  • France Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • France Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • UK Outlook (USD Billion, 2018-2032)







  • UK Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • UK Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • ITALY Outlook (USD Billion, 2018-2032)







  • ITALY Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • ITALY Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • SPAIN Outlook (USD Billion, 2018-2032)







  • SPAIN Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • SPAIN Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • Rest Of Europe Outlook (USD Billion, 2018-2032)







  • Rest Of Europe Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Rest Of Europe Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology







    • Others





  • Asia-Pacific Outlook (USD Billion, 2018-2032)






  • Asia-Pacific Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Asia-Pacific Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • China Outlook (USD Billion, 2018-2032)







  • China Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • China Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • Japan Outlook (USD Billion, 2018-2032)







  • Japan Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Japan Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • India Outlook (USD Billion, 2018-2032)







  • India Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • India Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • Australia Outlook (USD Billion, 2018-2032)







  • Australia Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Australia Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)







  • Rest of Asia-Pacific Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Rest of Asia-Pacific Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology







    • Others





  • Rest of the World Outlook (USD Billion, 2018-2032)






  • Rest of the World Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Rest of the World Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology




  • Others







    • Middle East Outlook (USD Billion, 2018-2032)







  • Middle East Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Middle East Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    • Africa Outlook (USD Billion, 2018-2032)







  • Africa Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Africa Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology








      • Others





    •  Latin America Outlook (USD Billion, 2018-2032)







  • Latin America Microbiome Sequencing Services by Technology






  • Sequencing by Litigation (SBL)




  • Sequencing by Synthesis (SBS)




  • Short Gun Sequencing




  • Targeted Gene Sequencing




  • RNA Sequencing




  • Others






  • Latin America Microbiome Sequencing Services by Application






  • Gastrointestinal Diseases




  • Infectious Diseases




  • CNS Diseases




  • Oncology







    • Others




Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents:

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunity Analysis

5.4 Pricing Analysis

Chapter 6 Global Microbiome Sequencing Services Market, by Technology

6.1 Overview

6.2 Sequencing by Litigation (SBL)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Sequencing by Synthesis (SBS)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Short Gun Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Targeted Gene Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 RNA Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Others

Chapter 7 Global Microbiome Sequencing Services Market, by Application

7.1 Overview

7.2 Gastro-Intestinal Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Infectious Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 CNS Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Oncology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Others

Chapter 8 Global Microbiome Sequencing Services Market, by End User

8.1 Overview

8.2 Research and Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Chapter 9 Global Microbiome Sequencing Services Market, by Region

9.1 Overview

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10 Competitive Landscape

10.1 Overview

10.2 Market Share Analysis

Chapter 11 Company Profiles

11.1 Baseclear B.V.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Clinical Microbiomics A/S

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 EPIBIOME

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Merieux Nutrisciences Corporations

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Metabiomics Corp.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Microbiome Insights Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Microbiome Therapeutics, LLC.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 MR DNA

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Rancho Biosciences

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Second Genome

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Ubiome, Inc.

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Zymo Research Corp.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Microbiome Sequencing Services Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Global Microbiome Sequencing Services Market Synopsis, 2020-2027

Table 2 Global Microbiome Sequencing Services Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 4 Global Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 5 Global Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 6 Global Microbiome Sequencing Services Market, by Region, 2020-2027(USD Million)

Table 7 North America: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 8 North America: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 9 North America: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 10 North America: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

Table 11 Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 12 Latin America: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 13 Latin America: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 14 Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 15 Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 16 Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 17 Europe: Microbiome Sequencing Services Market, by Region, 2020-2027 (USD Million)

Table 18 Western Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 19 Western Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 20 Western Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 21 Western Europe: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

Table 22 Eastern Europe: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 23 Eastern Europe: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 24 Eastern Europe: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 25 Asia-Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 26 Asia-Pacific: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 27 Asia-Pacific: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 28 Asia-Pacific: Microbiome Sequencing Services Market, by Country, 2020-2027 (USD Million)

Table 29 Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2027 (USD Million)

Table 30 Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Microbiome Sequencing Services Market, by End User, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Microbiome Sequencing Services Market, by Region, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Microbiome Sequencing Services Market

Figure 3 Segmentation Market Dynamics for Global Microbiome Sequencing Services Market

Figure 4 Global Microbiome Sequencing Services Market Share, by Technology, 2020 (%)

Figure 5 Global Microbiome Sequencing Services Market Share, by Application, 2020 (%)

Figure 6 Global Microbiome Sequencing Services Market Share, by End User, 2020 (%)

Figure 7 Global Microbiome Sequencing Services Market Share, by Region, 2020 (%)

Figure 8 North America: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

Figure 9 Europe: Microbiome Sequencing Services Market Share, by Region, 2020 (%)

Figure 10 Western Europe: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

Figure 11 Asia-Pacific: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

Figure 12 Middle East & Africa: Microbiome Sequencing Services Market Share, by Country, 2020 (%)

Figure 13 Global Microbiome Sequencing Services Market: Company Share Analysis, 2020 (%)

Figure 14 Baseclear B.V.: Key Financials

Figure 15 Baseclear B.V.: Segmental Revenue

Figure 16 Baseclear B.V.: Geographical Revenue

Figure 17 Clinical Microbiomics A/S: Key Financials

Figure 18 Clinical Microbiomics A/S: Segmental Revenue

Figure 19 Clinical Microbiomics A/S: Geographical Revenue

Figure 20 Microbiome Insights Inc.: Key Financials

Figure 21 Microbiome Insights Inc.: Segmental Revenue

Figure 22 Microbiome Insights Inc.: Geographical Revenue

Figure 23 Merieux Nutrisciences Corporation: Key Financials

Figure 24 Merieux Nutrisciences Corporation: Segmental Revenue

Figure 25 Merieux Nutrisciences Corporation: Geographical Revenue

NOTE:

This table of content is tentative and subject to change as the research progresses.

-In Chapter 11, the top 10 companies will be profiled. Each company will be profiled on the basis of Market Overview, Financials, Product Portfolio, Business Strategies, & Recent Development parameters.

-Please note: Financial details of the company cannot be provided if the information of the company is not available in the public domain and or reliable source

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.